These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8567229

  • 1. [To what extent can prostaglandin synthesis inhibitors of the non-steroidal antirheumatic (NSAR) type modify the effect of ACE inhibitors?].
    Grote L.
    Internist (Berl); 1995 Dec; 36(12):1203-4. PubMed ID: 8567229
    [No Abstract] [Full Text] [Related]

  • 2. Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction.
    Guazzi MD, Campodonico J, Celeste F, Guazzi M, Santambrogio G, Rossi M, Trabattoni D, Alimento M.
    Clin Pharmacol Ther; 1998 Jan; 63(1):79-86. PubMed ID: 9465844
    [Abstract] [Full Text] [Related]

  • 3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 4. [Practical questions about therapy of hypertension with ACE inhibitors. J. Scholze, Berlin, on the 24-hour effect, possible combinations and side-effects of ACE inhibitors--ASS/antirheumatic agents].
    Scholze J.
    Fortschr Med; 1995 Feb 10; 113(4):51-4. PubMed ID: 7713469
    [No Abstract] [Full Text] [Related]

  • 5. Effects of non-steroidal anti-inflammatory drugs on hypertension control using angiotensin converting enzyme inhibitors and thiazide diuretics.
    Bhagat K.
    East Afr Med J; 2001 Oct 10; 78(10):507-9. PubMed ID: 11921591
    [Abstract] [Full Text] [Related]

  • 6. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z, Armaly Z, Nakhoul F, Hoffman A.
    Harefuah; 2008 Jun 10; 147(6):536-42, 573. PubMed ID: 18693632
    [Abstract] [Full Text] [Related]

  • 7. Does aspirin interfere with the therapeutic efficacy of angiotensin-converting enzyme inhibitors in hypertension or congestive heart failure?
    Nawarskas JJ, Spinler SA.
    Pharmacotherapy; 1998 Jun 10; 18(5):1041-52. PubMed ID: 9758314
    [Abstract] [Full Text] [Related]

  • 8. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
    Probstfield J.
    J Fam Pract; 2009 Jun 10; 58(6 Suppl):S1-8. PubMed ID: 19508849
    [No Abstract] [Full Text] [Related]

  • 9. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE, Julius S.
    Am Heart J; 2004 Nov 10; 148(5):747-54. PubMed ID: 15523303
    [Abstract] [Full Text] [Related]

  • 10. [Hypertension 2007-2008].
    Chatzikyrkou C, Menne J, Haller H.
    Med Klin (Munich); 2009 Aug 10; 104(8):614-21. PubMed ID: 19701732
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive drugs and fibrinolytic function.
    Fogari R, Zoppi A.
    Am J Hypertens; 2006 Dec 10; 19(12):1293-9. PubMed ID: 17161777
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic possibilities for the inhibition of the renin-angiotensin-aldosterone system].
    Abrahám G, Légrády P.
    Orv Hetil; 2003 May 04; 144(18 Suppl 1):892-5. PubMed ID: 12785232
    [Abstract] [Full Text] [Related]

  • 13. [The antagonistic effect of aspirin on the expression of prostaglandin participation in the antihypertensive activity of ACE inhibitors].
    Alimento M, Campodonico J, Santambrogio G, Rossi M, Trabattoni D, Celeste F, Guazzi M.
    Cardiologia; 1997 Jun 04; 42(6):605-10. PubMed ID: 9289376
    [Abstract] [Full Text] [Related]

  • 14. More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension.
    Kjeldsen SE, Hedner T, Narkiewicz K, Oparil S.
    Blood Press; 2008 Jun 04; 17(3):132-3. PubMed ID: 18665471
    [No Abstract] [Full Text] [Related]

  • 15. [Hypertension combination therapy with renin-angiotensin system blockers].
    Soucek M.
    Vnitr Lek; 2009 Sep 04; 55(9):719-23. PubMed ID: 19785368
    [Abstract] [Full Text] [Related]

  • 16. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P.
    Vnitr Lek; 2006 Sep 04; 52(9):791-6. PubMed ID: 17091602
    [Abstract] [Full Text] [Related]

  • 17. Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: rationale and clinical relevance.
    Meune C, Mourad JJ, Bergmann JF, Spaulding C.
    J Renin Angiotensin Aldosterone Syst; 2003 Sep 04; 4(3):149-54. PubMed ID: 14608518
    [Abstract] [Full Text] [Related]

  • 18. Blockade of the renin-angiotensin-aldosterone system with combination angiotensin receptor antagonist and ACE inhibitor therapy: observations from Val-HeFT and CALM.
    Chin BS, Lip GY.
    J Hum Hypertens; 2001 Feb 04; 15(2):89-92. PubMed ID: 11317186
    [No Abstract] [Full Text] [Related]

  • 19. [Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure].
    Andersen RS, Christensen S.
    Ugeskr Laeger; 2001 Dec 10; 163(50):7036-9. PubMed ID: 11794033
    [Abstract] [Full Text] [Related]

  • 20. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.
    Wallis EJ, Ramsay LE, Hettiarachchi J.
    Clin Pharmacol Ther; 1998 Oct 10; 64(4):439-49. PubMed ID: 9797801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.